-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 A6X4QX8bILH2ndQ/Q7KDJpQ3yAAvafUx+Z6pGtQeZnr+h9qz8GgxOzRVky0NfjRJ
 WHGkHDdGGHzV7pGREs0PGw==

<SEC-DOCUMENT>0000950123-11-000984.txt : 20110106
<SEC-HEADER>0000950123-11-000984.hdr.sgml : 20110106
<ACCEPTANCE-DATETIME>20110106131642
ACCESSION NUMBER:		0000950123-11-000984
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20110106
FILED AS OF DATE:		20110106
DATE AS OF CHANGE:		20110106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Concord Medical Services Holdings Ltd
		CENTRAL INDEX KEY:			0001472072
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34563
		FILM NUMBER:		11513521

	BUSINESS ADDRESS:	
		STREET 1:		ROOM 2001-2002, 20TH FLOOR, TOWER A
		STREET 2:		GLOBAL TRADE CTR, 36 NORTH THIRD RING RD
		CITY:			DONGCHENG DISTRICT, BEIJING
		STATE:			F4
		ZIP:			100013
		BUSINESS PHONE:		(86)10-5825-6867

	MAIL ADDRESS:	
		STREET 1:		ROOM 2001-2002, 20TH FLOOR, TOWER A
		STREET 2:		GLOBAL TRADE CTR, 36 NORTH THIRD RING RD
		CITY:			DONGCHENG DISTRICT, BEIJING
		STATE:			F4
		ZIP:			100013
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>h04750e6vk.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
<TITLE>Form 6-K</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>WASHINGTON D.C. 20549</B>
</DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM
6-K</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>REPORT OF FOREIGN PRIVATE ISSUER<BR>
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE<BR>
SECURITIES EXCHANGE ACT OF 1934</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>For
the month of January 2011</B></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="FONT-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Commission File Number: 001-34563</B></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="FONT-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 22pt; margin-top: 12pt"><B>CONCORD MEDICAL SERVICES HOLDINGS LIMITED</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">18/F, Tower A, Global Trade Center<BR>
36 North Third Ring Road East, Dongcheng District<BR>
Beijing 100013<BR>
People&#146;s Republic of China<BR>
(Address of principal executive offices)</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Indicate by check mark whether the registrant files or will file annual reports under cover Form
20-F or Form 40-F.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">Form&nbsp;20-F <FONT style="font-family: Wingdings">&#254;</FONT> &nbsp;Form&nbsp;40-F <FONT style="font-family: Wingdings">&#111;</FONT></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation&nbsp;S-T Rule&nbsp;101(b)(1):
<FONT style="font-family: Wingdings">&#111;</FONT>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation&nbsp;S-T Rule&nbsp;101(b)(7):
<FONT style="font-family: Wingdings">&#111;</FONT>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Indicate by check mark whether by furnishing the information contained in this Form, the registrant
is also thereby furnishing the information to the Commission pursuant to Rule&nbsp;12g3-2(b) under the
Securities Exchange Act of 1934.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">Yes <FONT style="font-family: Wingdings">&#111;</FONT> No <FONT style="font-family: Wingdings">&#254;</FONT></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">If &#147;Yes&#148; is marked, indicate below the file number assigned to the registrant in connection with
Rule&nbsp;12g3-2(b): <U>&nbsp;&nbsp;N/A&nbsp;&nbsp;</U>
</DIV>




<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>













<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<!-- TOC -->
<A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>

<P><CENTER>
<TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
<TR>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="76%"></TD>
</TR>
<TR><TD colspan="9"><A HREF="#000">SIGNATURE</A></TD></TR>
<TR><TD colspan="9"><A HREF="h04750exv99w1.htm">EX-99.1</A></TD></TR>
</TABLE>
</CENTER>
<!-- /TOC -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>







<DIV align="center" style="font-size: 10pt; margin-top: 18pt">TABLE OF CONTENTS
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Exhibit&nbsp;99.1
&#150; Press release dated January 6, 2011
</DIV>







<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>


<DIV style="font-family: 'Times New Roman',Times,serif">


<!-- link1 "SIGNATURE" -->
<DIV align="left"><A NAME="000"></A></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">SIGNATURE
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left" nowrap>CONCORD MEDICAL SERVICES
HOLDINGS LIMITED<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>

<TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/
Jianyu Yang&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">Jianyu Yang&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left" nowrap>Director, Chief Executive Officer and President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Date:
January 6, 2011
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>h04750exv99w1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;99.1</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Concord Medical to Acquire A 52% Equity Interest in Chang&#146;An Hospital<BR>
Updates on Progress of CCICC</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">BEIJING, January&nbsp;6, 2011 &#151; Concord Medical Services Holdings Limited (&#147;Concord Medical&#148; or the
&#147;Company&#148;) (NYSE: CCM), the operator of the largest network of radiotherapy and diagnostic imaging
centers in China, today announced that it has, through its subsidiaries, entered into agreements to
acquire a total of 52% equity interest in Chang&#146;An Hospital (the &#147;Hospital&#148;), a licensed
full-service private hospital, from certain shareholders of the Hospital for a total consideration
of approximately RMB 200&nbsp;million. The closing of this acquisition is subject to satisfactory due
diligence by the Company of the Hospital and relevant government approval.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Concord Medical has been managing Chang&#146;An Hospital under an entrusted management contract since
August&nbsp;2008. In July&nbsp;2010, Concord Medical formed Chang&#146;An CMS International Cancer Center
(&#147;CCICC&#148;), a specialized cancer diagnosis and treatment center consisting of over 300 hospital beds
in Xi&#146;an, with the Hospital by acquiring a 52% equity interests in the Hospital&#146;s cancer treatment
facilities. The acquisition of a controlling equity interest in the Hospital is driven by robust
demand for cancer diagnosis and treatment services in the region. The acquisition furthers the
development of CCICC by giving Concord Medical effective control over the full capacity of 1,100
beds in the Hospital. After this acquisition, Concord Medical plans to transform Chang&#146;An Hospital
into a full-service hospital with a special focus on cancer diagnosis and treatment services.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&#147;Preliminary operation results at CCICC have been very encouraging.&#148; Dr.&nbsp;Jianyu Yang, director,
president and chief executive officer of Concord Medical commented. &#147;We see this acquisition as
another step forward toward building our first specialized cancer treatment hospital in China, in
which we will be able to serve more patients with better services. We are committed to our strategy
of expanding our treatment network while improving operational efficiency and advancing our
technologies.&#148;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U><B>About Concord Medical</B></U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Concord Medical operates the largest network of radiotherapy and diagnostic imaging centers in
China in terms of revenues and the total number of centers in operation per available statistics.
The Company currently operates a network of more than 111 centers spanning 41 cities and 23
provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals
in China, the Company provides radiotherapy and diagnostic imaging equipments and manages the daily
operations of these centers located on its hospital partners&#146; premises. The Company also provides
ongoing training to doctors and other medical personnel in its network of centers to ensure a high
level of clinical care for patients.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><U><B>Safe Harbor Statement</B></U><BR>
This press release contains forward-looking statements. These statements constitute
&#147;forward-looking&#148; statements within the meaning of Section&nbsp;21E of the Securities Exchange Act of
1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995.
These forward-looking statements can be identified by terminology such as &#147;anticipate,&#148; &#147;believe,&#148;
&#147;estimate,&#148; &#147;expect,&#148; &#147;forecast,&#148; &#147;intend,&#148; &#147;may,&#148; &#147;plan,&#148; &#147;project,&#148; &#147;predict,&#148; &#147;should&#148; and
&#147;will&#148; and similar expressions. These forward looking statements are based upon management&#146;s
current views and expectations with respect to future events and are not a guarantee of future
performance. Furthermore, these statements are, by their nature, subject to a number of risks and
uncertainties that could cause actual performance and results to differ materially from those
discussed in the forward-looking statements as a result of a number of factors. Such factors
include: the number of new radiotherapy and diagnostic imaging centers opened; the increase in the
number of patients in existing centers; the establishment of specialty cancer hospitals; changes in
the healthcare industry in China, including changes in the healthcare policies and regulations of
the PRC government; and technological or therapeutic changes affecting the field of cancer
treatment and diagnostic imaging. Further information regarding these and other risks is included
in the Company&#146;s filings with the U.S. Securities and Exchange Commission at www.sec.gov. The
Company does not undertake any obligation to update any forward-looking statement, except as
required under applicable law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 32pt">For investor and media inquiries please contact:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 24pt">China
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Tony Tian<BR>
Concord Medical Services<BR>
&#043;86-10-5957-5287<BR>
tony.tian@cmsholdings.com

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Lilian Wong<BR>
Brunswick Group, LLC<BR>
&#043;86-10-6566-2256<BR>
lwong@brunswickgroup.com

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 24pt">U.S.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Nicki Kahner<BR>
Brunswick Group, LLC<BR>
&#043;1-212-333-3810<BR>
nkahner@brunswickgroup.com

</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
